Can occult infections or malignancies elevate Hemoglobin A1c (HbA1c) levels despite good Self-Monitoring of Blood Glucose (SMBG) readings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Occult Infections and Malignancies Can Elevate HbA1c Despite Normal SMBG Readings

Yes, occult infections and malignancies can cause elevated HbA1c levels despite good self-monitoring blood glucose (SMBG) readings, primarily through mechanisms that affect red blood cell lifespan and turnover. 1

Mechanisms of HbA1c Elevation in Occult Disease

  • Any condition that slows erythropoiesis or prolongs red blood cell lifespan can increase HbA1c values independent of actual glycemic control 2
  • Occult malignancies, particularly those affecting bone marrow function, can alter red blood cell production and lifespan, leading to falsely elevated HbA1c 1
  • Chronic infections may cause inflammatory responses that affect red blood cell turnover, potentially resulting in higher HbA1c values than would be expected based on blood glucose levels 1
  • Iron deficiency anemia, which can be associated with occult malignancies (especially gastrointestinal), prolongs erythrocyte lifespan and can cause falsely elevated HbA1c 2, 3

Common Causes of Discrepancy Between HbA1c and SMBG

  • Conditions affecting red blood cell lifespan:
    • Prolonged RBC lifespan (iron deficiency anemia, aplastic anemia) increases HbA1c 2, 3
    • Shortened RBC lifespan (hemolytic anemia, recovery from blood loss) decreases HbA1c 2
  • Limited SMBG testing frequency may miss significant glycemic excursions, particularly postprandial hyperglycemia 1
  • Operator-related errors in SMBG technique (improper calibration, poor hand washing, dirty meters) 1

Clinical Implications

  • HbA1c should be interpreted with caution when there is a discrepancy with SMBG readings, especially in patients with suspected occult disease 2
  • For approximately 20% of people with diabetes, HbA1c levels are substantially higher or lower than would be predicted from mean blood glucose levels 4
  • When HbA1c values seem discordant with clinical presentation or SMBG results, consider occult conditions as potential confounding factors 1, 5

Evaluation Steps for Discrepant HbA1c and SMBG

  1. Evaluate the patient's monitoring technique and frequency 1
  2. Consider testing during different times of day, including postprandial periods 1
  3. Investigate for conditions that might affect red blood cell lifespan:
    • Complete blood count to assess for anemia 3
    • Iron studies to evaluate for iron deficiency 2, 3
    • Evaluation for occult infection or malignancy when clinically suspected 1

Management Recommendations

  • When HbA1c is suspected to be unreliable due to occult disease, consider alternative measures of glycemic control 1:
    • Fructosamine or glycated albumin measurements 6
    • Continuous glucose monitoring (CGM) to better understand glycemic patterns 1, 5
    • Structured SMBG testing at various times of day 1
  • A hemoglobin variant or interference should be suspected if the HbA1c reading is surprisingly high or low, or significantly changed coincident with a change in laboratory method 2
  • In cases of suspected interference, correlation with other glycemic measures (fasting glucose, post-prandial glucose) is essential to establish true glycemic status 7

Pitfalls and Caveats

  • Relying solely on HbA1c without considering potential confounding factors can lead to inappropriate treatment intensification 2
  • Sequential HbA1c values that are within 0.5% do not statistically differ from one another unless the assay coefficient of variation is less than 3% 2
  • Comparing HbA1c tests performed in different clinical laboratories introduces another source of error 2
  • Point-of-care HbA1c testing is not subject to systematic quality oversight and may be less reliable 2

Understanding these factors is crucial for accurate interpretation of glycemic control in patients with suspected occult disease and for making appropriate treatment decisions.

References

Guideline

Elevated Glycohemoglobin (HbA1c) Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anemia's Impact on Glycemic Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beyond HbA1c.

Journal of diabetes, 2017

Research

Is HbA1c an ideal biomarker of well-controlled diabetes?

Postgraduate medical journal, 2021

Guideline

Lymphocytic Leukemia and HbA1c Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.